Carregant...
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy
The accompanying perspective by Drs. Falini and Martelli provides a clear description of the current WHO classification with a focus on the distinction between ALK-positive anaplastic large cell lymphoma ALCL and ALK-negative disease. Additionally, they provide a rationale for potential new targets...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ferrata Storti Foundation
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2704299/ https://ncbi.nlm.nih.gov/pubmed/19570751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.008250 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|